BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ARO-MAPT-SC readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ARO-MAPT-SC\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07221344-694@assetmemo.bio
DTSTAMP:20261121T005843Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:ARO-MAPT-SC: Phase 1/2 readout est. (NCT07221344)
DESCRIPTION:ARO-MAPT-SC\, phase 1/2\, Alzheimer's Disease.\nStudy: Trial of
  ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer
 's Disease or Primary Tauopathies\nEstimated primary completion: June 2027
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/aro-mapt-sc#upcomin
 g-events\nRegistry record: https://clinicaltrials.gov/study/NCT07221344
URL:https://assetmemo.bio/drug/aro-mapt-sc#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
